CMND
HEALTHCAREClearmind Medicine Inc
$0.56-0.05 (-8.42%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving CMND Today?
No stock-specific AI insight has been generated for CMND yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.52$52.40
$0.56
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-24.12
Dividend Yield—
Dividend / Share—
ROE-1.2%
Profit Margin—
Debt / Equity—
Trading
Volume862K
Avg Volume (10D)—
Shares Outstanding10.2M
CMND News
20 articles- Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSDYahoo Finance·May 5, 2026
- Weekly Roundup on the Cannabis Sector & Psychedelic SectorYahoo Finance·Apr 27, 2026
- Clearmind Medicine Announces Evaluation of its Psychedelic-Based Treatment (MEAI) for Potential FDA Breakthrough Therapy DesignationYahoo Finance·Apr 27, 2026
- FDA Fast-Tracks Psychedelic Drug Research Following Trump Directive; Psychedelic Drug Makers GainYahoo Finance·Apr 24, 2026
- Clearmind Medicine Welcomes President Trump’s Executive Order as a Historic Catalyst for Psychedelic Innovation and Veteran Mental Health CareYahoo Finance·Apr 20, 2026
- Psychedelic Shares Rise Following Trump's Executive Order to Accelerate Treatments for Serious Mental IllnessYahoo Finance·Apr 20, 2026
- Clearmind Medicine Announced Positive Top-Line Safety Results: CMND-100 Proprietary Psychedelic Treatment Meets Primary Endpoint in AUD TrialYahoo Finance·Apr 20, 2026
- Trump Trade: President to sign order on psychedelic used for PTSDYahoo Finance·Apr 17, 2026
- Clearmind Medicine Announces Positive Data Safety Monitoring Board Recommendation in ongoing CMND-100 clinical trialYahoo Finance·Apr 15, 2026
- Clearmind Medicine’s CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use DisorderYahoo Finance·Apr 14, 2026
- Clearmind Medicine Announces Successful Completion of Treatment and Follow-up for 18 Participants in its Ongoing Phase I/IIa Clinical Trial of CMND-100 for Alcohol Use DisorderYahoo Finance·Mar 30, 2026
- Clearmind Medicine Files Patent Application in India for Next-Gen Psychedelic Compounds to Treat Mental Health DisordersYahoo Finance·Mar 27, 2026
- Clearmind Medicine Reports Successful Ongoing Treatment of Participants at US Sites in its FDA-approved CMND-100 Phase I/IIa Clinical Trial for Alcohol Use DisorderYahoo Finance·Mar 19, 2026
- Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination TherapiesYahoo Finance·Mar 17, 2026
- SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression TherapyYahoo Finance·Mar 16, 2026
- NeuroThera Labs - Clearmind Medicine Collaboration Leads to Patent Application for Depression TherapyYahoo Finance·Mar 16, 2026
- Clearmind Medicine Announces Hong Kong Patent Filing for Depression TherapyYahoo Finance·Mar 13, 2026
- SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver DiseaseYahoo Finance·Mar 12, 2026
- Clearmind Medicine Advances Recruitment for CMND-100 Trial's Third Cohort at Yale, Johns Hopkins and Tel Aviv Sites Following Recent Positive Topline ResultsYahoo Finance·Mar 11, 2026
- NeuroThera Labs Announces Publication of International Patent in Collaboration With Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver DiseaseYahoo Finance·Mar 11, 2026
All 20 articles loaded
Price Data
Open$0.60
Previous Close$0.61
Day High$0.60
Day Low$0.52
52 Week High$52.40
52 Week Low$0.52
52-Week Range
$0.52$52.40
$0.56
Fundamentals
Market Cap$6M
P/E Ratio—
EPS$-24.12
Dividend Yield—
Dividend / Share—
ROE-1.2%
Profit Margin—
Debt / Equity—
Trading
Volume862K
Avg Volume (10D)—
Shares Outstanding10.2M
About Clearmind Medicine Inc
Clearmind Medicine Inc., a preclinical pharmaceutical company, develops new psychedelic drugs to treat neglected health problems. The company is headquartered in Vancouver, Canada.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—